Medical News

---

• EDS identifies dysphagia patients at high risk for esophageal cancer
• EDS identifies dysphagia patients at high risk for esophageal cancer
• Pre-surgery anti-platelet factor 4/heparin antibody levels not linked to HIT
• Prior antiplatelet use impacts on ICH outcomes
• Impact of obesity on PSA explains low prostate cancer incidence
• High Gleason score at prostatectomy does not guarantee worse survival
• Impact of obesity on PSA explains low prostate cancer incidence
• High Gleason score at prostatectomy does not guarantee worse survival
• Breast cancer diagnosis could be improved by studying calcium deposits
• Genetically high apoA-1 levels do not affect IHD or MI risk
• High vitamin D levels linked to favorable lipid profile
• Linagliptin effective and well tolerated in combination with metformin
• Poor response to darbepoetin alfa linked to elevated adverse events seen in TREAT
• Anatomical variation increases esophageal damage risk during AF ablation
• Dual, triple anticoagulation therapy for AF may triple bleeding risk
• Breast cancer diagnosis could be improved by studying calcium deposits
• PSA test at 60 years predicts risk for prostate cancer death by 85
• Age, cognitive reserve affect post-chemotherapy cognitive function
• Prostate cancer screening only benefits men with elevated PSA
• Prostate cancer risk genes also predict disease progression
• Breast cancer recurrence low following intraoperative radiotherapy
• No significant adverse effects after deferring radical prostatectomy
• Locoregional therapy recommended for node positive occult breast cancer

EDS identifies dysphagia patients at high risk for esophageal cancer Posted: 16 Sep 2010 05:00 PM PDT The Edinburgh Dysphagia Score effectively identifies patients who are at high risk for esophageal cancer, report researchers.

EDS identifies dysphagia patients at high risk for esophageal cancer Posted: 16 Sep 2010 05:00 PM PDT The Edinburgh Dysphagia Score effectively identifies patients who are at high risk for esophageal cancer, report researchers.

Pre-surgery anti-platelet factor 4/heparin antibody levels not linked to HIT Posted: 15 Sep 2010 05:00 PM PDT The presence of anti-platelet factor 4/heparin antibodies of any immunoglobulin class before cardiac surgery is not associated with an increased risk for heparin-induced thrombocytopenia, say researchers.

Prior antiplatelet use impacts on ICH outcomes Posted: 15 Sep 2010 05:00 PM PDT Patients taking antiplatelet agents may be at increased risk for dying in the event of an intracerebral hemorrhage, say the authors of a systematic review.

Impact of obesity on PSA explains low prostate cancer incidence Posted: 15 Sep 2010 05:00 PM PDT Obese men are less likely than lean men to reach the prostate-specific antigen threshold for prostate biopsy, thereby reducing their likelihood of a diagnosis of prostate cancer, report US researchers.

High Gleason score at prostatectomy does not guarantee worse survival Posted: 15 Sep 2010 05:00 PM PDT Certain men with a high Gleason score at radical prostatectomy can have good cancer-specific survival rates in the 15 years after surgery, despite being highly likely to experience biochemical recurrence during that time, show US study results.

Impact of obesity on PSA explains low prostate cancer incidence Posted: 15 Sep 2010 05:00 PM PDT Obese men are less likely than lean men to reach the prostate-specific antigen threshold for prostate biopsy, thereby reducing their likelihood of a diagnosis of prostate cancer, report US researchers.

High Gleason score at prostatectomy does not guarantee worse survival Posted: 15 Sep 2010 05:00 PM PDT Certain men with a high Gleason score at radical prostatectomy can have good cancer-specific survival rates in the 15 years after surgery, despite being highly likely to experience biochemical recurrence during that time, show US study results.

Breast cancer diagnosis could be improved by studying calcium deposits Posted: 15 Sep 2010 05:00 PM PDT Infrared analysis of breast tissue microcalcifications could allow clinicians to discriminate between benign and malignant breast tumors without the need for biopsy, UK researchers report.

Genetically high apoA-1 levels do not affect IHD or MI risk Posted: 15 Sep 2010 05:00 PM PDT People with genetically elevated levels of apolipoprotein A-1 and high-density lipoprotein cholesterol do not have a reduced risk for ischemic heart disease or myocardial infarction, research shows.

High vitamin D levels linked to favorable lipid profile Posted: 15 Sep 2010 05:00 PM PDT People with high levels of the marker of vitamin D status 25-hydroxyvitamin D have favorable lipid profiles, say Norwegian researchers.

Linagliptin effective and well tolerated in combination with metformin Posted: 15 Sep 2010 05:00 PM PDT Linagliptin is an effective and well-tolerated addition to metformin treatment for reducing glycated hemoglobin in patients with Type 2 diabetes, show study findings.

Poor response to darbepoetin alfa linked to elevated adverse events seen in TREAT Posted: 15 Sep 2010 05:00 PM PDT Results from an analysis of the TREAT study suggest that diabetes patients with chronic kidney disease and moderate anemia who had a poor response to the anemia drug darbepoetin alfa were more likely to have an adverse cardiovascular outcome than those with a better response, despite receiving a higher mean dose.

Anatomical variation increases esophageal damage risk during AF ablation Posted: 15 Sep 2010 05:00 PM PDT Researchers report that atrial fibrillation patients with specific anatomical variations may have an increased risk for esophageal ulceration after radio frequency ablation.

Dual, triple anticoagulation therapy for AF may triple bleeding risk Posted: 15 Sep 2010 05:00 PM PDT Adding clopidogrel, with or without aspirin, to warfarin in anticoagulation therapy for atrial fibrillation may increase patients' bleeding risk at least three-fold, research indicates.

Breast cancer diagnosis could be improved by studying calcium deposits Posted: 15 Sep 2010 05:00 PM PDT Infrared analysis of breast tissue microcalcifications could allow clinicians to discriminate between benign and malignant breast tumors without the need for biopsy, UK researchers report.

PSA test at 60 years predicts risk for prostate cancer death by 85 Posted: 14 Sep 2010 05:00 PM PDT The prostate-specific antigen levels of 60-year old men can predict the likelihood of death from the disease in the subsequent 25 years, report researchers.

Age, cognitive reserve affect post-chemotherapy cognitive function Posted: 14 Sep 2010 05:00 PM PDT Age and pretreatment cognitive reserve are important predictors of post-treatment processing speed among patients undergoing chemotherapy for breast cancer, US researchers report.

Prostate cancer screening only benefits men with elevated PSA Posted: 13 Sep 2010 05:00 PM PDT Continued prostate cancer screening among men aged 55–74 years is only beneficial if they have an initially elevated prostate-specific antigen level, show the results of a Dutch study.

Prostate cancer risk genes also predict disease progression Posted: 13 Sep 2010 05:00 PM PDT Five out of 26 single nucleotide polymorphisms recently associated with a risk for prostate cancer are also able to predict progression in men who already have the disease, say researchers.

Breast cancer recurrence low following intraoperative radiotherapy Posted: 13 Sep 2010 05:00 PM PDT Intraoperative radiotherapy using low-kilovoltage X-rays during breast-conserving surgery for breast cancer yields low recurrence and toxicity rates, German research shows.

No significant adverse effects after deferring radical prostatectomy Posted: 12 Sep 2010 05:00 PM PDT Men with prostate cancer do not have more adverse disease features if they undergo radical prostatectomy after a period of active surveillance, instead of immediately after diagnosis, say Swedish researchers.

Locoregional therapy recommended for node positive occult breast cancer Posted: 12 Sep 2010 05:00 PM PDT Definitive locoregional treatment with mastectomy or breast-conserving therapy improves the outcome of patients with axillary lymph node metastasis from an occult primary breast cancer, compared with more conservative treatments, US researchers report.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610